REFERENCE. Admit to: Program/Service: Diagnosis: Droplet/ Contact Airborne/ Contact



Similar documents
General PROVIDER INITIALS: PHYSICIAN ORDERS

How To Treat An Alcoholic Patient

Managing Patients with Alcohol Withdrawal

Alcohol Withdrawal. Mild Withdrawal Moderate Withdrawal Severe Withdrawal. Mild anxiety Malaise Marked anxiety

Chronic Obstructive Pulmonary Disease (COPD) Admission Order Set

Assessment and management of alcohol dependence and withdrawal in the acute hospital

Phenobarbital in Severe Alcohol Withdrawal Syndrome. Jordan Rowe Pharm.D. Candidate UAMS College of Pharmacy

University of Michigan Alcohol Withdrawal Guidelines Overview

Substance Use Learning Event Nov 3, 2015 Bill Bullock MD, CCFP

Does This Hospital Serve Cocktails? Alcohol Withdrawal: A Nursing Perspective. Written and presented by: Susan Laffan, RN, CCHP-RN, CCHP-A

Phenobarbital Use as Adjunct to Benzodiazepines in the Treatment of Severe Alcohol Withdrawal Syndrome

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Symptom Based Alcohol Withdrawal Treatment

SLIDING SCALE INSULIN REGULAR PLAN

Glasgow Assessment and Management of Alcohol

Live Person Simulation Scenario Psychiatric and Mental Health Nursing (Sandra)

Alcohol information. A standard drink contains about 10g of alcohol takes a healthy liver about 1 hour to remove alcohol from the body.

Supported Alcohol Withdrawal Treatment Information

SLIDING SCALE INSULIN ASPART PROTOCOL PLAN

Title Alcohol Withdrawal Management Guidelines

INTOXICATED PATIENTS AND DETOXIFICATION

[ ] POCT glucose Routine, As needed, If long acting insulin is given and patient NPO, do POCT glucose every 2 hours until patient eats.

Development and Implementation of an Evidence-Based Alcohol Withdrawal Order Set. Kathleen Lenaghan MSN, RN-BC

Alcohol Withdrawal Syndrome & CIWA Assessment

Care of the Patient Undergoing Alcohol Withdrawal. Meggen Platzar RN, BSN, CMSRN Jennifer Wilhelm RN, BSN, CMSRN

MANAGEMENT OF ALCOHOL PROBLEMS ON PSYCHIATRIC WARDS

NewYork-Presbyterian Hospital Sites: All Centers Medication Use Manual: Guideline Page 1 of 12

Management of benzodiazepine misuse

2.6.4 Medication for withdrawal syndrome

YCN Head & Neck NSSG Alcohol Assessment and Detoxification Management Guidelines

Alcohol Withdrawal in the AMU. Dr Ewan Forrest Glasgow Royal Infirmary

Alcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol

HUMULIN R REGULAR INSULIN HUMAN INJECTION, USP (rdna ORIGIN) 100 UNITS PER ML (U-100)

GP Drug & Alcohol Supplement No.7 May 1997

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

ALCOHOL DETOXIFICATION (IN-PATIENTS) PRESCRIBING GUIDELINE

INR: RUPTURED ANEURYSM: POST EMBOLIZATION Patient Identification Page 1 of 5. Allergies: Weight: kg Diagnosis:

Pharmacological Management of Acute Alcohol Withdrawal and Relapse Prevention in alcohol Use disorders in the Community

Outpatient Treatment of Alcohol Withdrawal. Daniel Duhigg, DO, MBA

Lorraine Wilson, 74 years of age, is admitted. Alcohol Withdrawal. During Hospitalization. Early recognition and consistent intervention are critical.

THE BASICS. Community Based Medically Assisted Alcohol Withdrawal. World Health Organisation The Issues 5/18/2011. RCGP Conference May 2011

Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services

Case. History of psoriatic arthritis, htn, essential tremor Meds: propranolol, etodolac, etanercept No history of prior psychiatric disease.

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

Alcohol Withdrawal. Julie Teater, MD Associate Professor - Clinical Department of Psychiatry The Ohio State University Wexner Medical Center

VALIUM PRODUCT MONOGRAPH. diazepam. 5 mg Tablets. Anxiolytic-sedative. Date of Revision: February 7, 2014

Alcohol and nicotine are widely abused substances and are often used together One study showed that 15% of patients visiting a primary care practice

Alcohol Withdrawal and Delirium

Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I

Review of Pharmacological Pain Management

EMS Branch / Office of the Medical Director. Active Seziures (d) Yes Yes Yes Yes. Yes Yes No No. Agitation (f) No Yes Yes No.

Coping With Alcohol Withdrawal

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing!

Adult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.

PHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION

Alcohol Withdrawal Recognition and Treatment

CORRECTIONAL HEALTHCARE WEBINAR

Management of Diabetes

BENZODIAZEPINES. Benzodiazepines may be habit-forming (causing mental or physical dependence), especially when taken for a long time or in high doses.

Alcohol withdrawal A challenge in caring for patients after heart surgery

SECTION N: MEDICATIONS. N0300: Injections. Item Rationale Health-related Quality of Life. Planning for Care. Steps for Assessment. Coding Instructions

Alcohol Dependence Inpatient management of Alcohol Withdrawal

1. According to recent US national estimates, which of the following substances is associated

How To Treat Alcohol Withdrawal In The Elderly

Symptom-Triggered Alcohol Detoxification: A Guideline for use in the Clinical Decisions Unit of the Emergency Department.

Pain Medication Taper Regimen Time frame to taper off days

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes

Alcohol Liaison Service. Alcohol Withdrawal. Information

Medicines To Treat Alcohol Use Disorder A Review of the Research for Adults

Clinical Pathway Total Hip and Knee Replacement

Share the important information in this Medication Guide with members of your household.

A COMPARATIVE STUDY OF EFFICACY & TOLERABILITY OF LORAZEPAM AND GABAPENTIN IN THE TREATMENT OF ALCOHOL WITHDRAWAL SYNDROME

SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D]

CARDIAC SURGERY INTRAVENOUS INSULIN PROTOCOL PHYSICIAN ORDERS INDICATIONS EXCLUSIONS. Insulin allergy

ALCOHOL ASSESSMENT AND DETOXIFICATION POLICY FOR INPATIENTS

Alcohol Withdrawal Syndromes

1 2 INFORMATION FOR THE PATIENT 3 10 ml Vial (1000 Units per vial)

Guidelines for Titration onto Buprenorphine in Opioid Dependence

A Manic Episode is defined by a distinct period during which there is an abnormally and persistently elevated, expansive, or irritable mood.

DVT/PE Management with Rivaroxaban (Xarelto)

Lidocaine Infusion for Perioperative Pain Management. Marley Linder, PharmD Matt McEvoy, MD

Version 2 This guideline describes how to manage patients who are showing signs and symptoms of alcohol withdrawal and Wernicke s Encephalopathy.

BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP)

Reintegration. Recovery. Medication-Assisted Treatment for Alcohol Dependence. Reintegration. Resilience

Alcohol. Problems with drinking alcohol

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

RESIDENT ASSESSMENT TOOL

ALCOHOL ASSESSMENT AND DETOXIFICATION POLICY FOR INPATIENTS

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

NEW ZEALAND CONSUMER MEDICINE INFORMATION Arrow - Diazepam

Alcohol Abuse and Addiction Management Protocol

Planning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation

Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth

Trust Clinical Policy. Directorate/Department/Specialist Group Emergency Department, Medical Admissions Unit and All wards and Departments

Transcription:

Weight (kg) REFER TO THE ALLERGY SCREEN IN MEDITECH FOR ALLERGY INFORMATION To complete the order form, fill in the required blanks and/or check the appropriate boxes. To delete orders, draw one line through the item and initial. Admit to: Program/Service: Diagnosis: Infection Control Precautions: Date: Time: Contact Airborne THIS PPO MUST BE FAXED TO PHARMACY Droplet/ Contact Airborne/ Contact Initial Clinical Institute Withdrawal Assessment Alcohol (CIWA-Ar) Score (refer to page ): Initial Sedation Score (refer to page 4): Consults: Psychiatry OT Re: Dietitian: assess and implement nutrition therapy Other: Diet: Regular Diet Other Diet: Activity: AAT, Ambulation with assistance if Clinical Institute Withdrawal Assessment Alcohol (CIWA-Ar) is less Assessments and Monitoring: Vital signs (Temp, HR, RR, BP, SpO), CIWA-Ar score and sedation score Vital signs q1h if on PO diazepam or SL LORazepam until CIWA-Ar score is less for two consecutive assessments and then vital signs q4h and PRN Vital signs q 0 minutes if on IV diazepam or IV LORazepam until CIWA-Ar score is less for two consecutive assessments and then vital signs q4h and PRN Titrate O to keep SpO greater than or equal to 9% or Notify RT if O requirements exceed FiO greater than 40% or L/minute Intake and Output q shift Initial Lab Investigations (if not already done): CBC, Lytes, Glucose (GLU), Creatinine, GGT, Mg, PO4, Corrected Calcium (includes Calcium and Albumin), AST, ALT, ALP, Bilirubin (TBILI) Blood Alcohol (ETHYL), Serum osmolality (OSMO) Urine Drug Screen (URDRUGSCR) Other: PT Re: SW Re: Capillary glucose q INR, PT, aptt (PTT) before each dose of diazepam or LORazepam IV Fluids: Saline Lock 0.9% NaCl / + 1/ DW Other: Rate: ml/h for hours then then Saline Lock Additive: With 0 mmol KCl/L of IV fluid With 40 mmol KCl/L of IV fluid Other: Discontinue IV when drinking well. Other: Complete additional orders on page PRESCRIBER SIGNATURE 00 D HR (December/01) Page 1 of

Clinical Institute Withdrawal Assessment Alcohol (CIWA-Ar) Score Nausea & Vomiting: Ask Do you feel sick to your stomach? Have you vomited? 0 No nausea & no vomiting 1 Mild nausea with no vomiting 4 Intermittent nausea & dry heaves 7 Constant nausea, frequent dry heaves Tremor: Ask patient to extend arms and spread fingers apart. Observation: 0 No tremor 1 Tremor not visible but can be felt, finger tip to finger tip 4 Moderate tremor with arms extended 7 Severe tremor, even with arms extended Paroxysmal sweats: Observation 0 No sweat visible 1 Barely perceptible sweating; palms moist 4 Beads of sweat obvious on forehead 7 Drenching sweats Anxiety: Ask Do you feel anxious? 0 No anxiety 1 Mildly anxious 4 Moderately anxious or guarded, so anxiety is inferred 7 Equivalent to acute panic states as occur in severe delirium or acute schizophrenic reactions Agitation: Observation 0 Normal activity 1 Somewhat more than normal activity 4 Moderately fidgety and restless 7 Paces back and forth during most of the interview or constantly thrashes about Tactile Disturbances: Ask Do you have any itching, pins-&-needles sensations, burning, or numbness, or do you feel like bugs are crawling on or under your skin? 0 None 1 Very mild itching, pins-&-needles, burning or numbness sensations Mild itching, pins-&-needles, burning, numbness sensation Moderate 4 Moderately severe hallucinations Severe hallucinations Extremely severe hallucinations 7 Continuous hallucinations Auditory Disturbances: Ask Are you more aware of sounds around you? Are they harsh? Do they frighten you? Are you hearing anything that is disturbing you? Are you hearing things you know are not there? 0 Not present 1 Very mild harshness or ability to frighten Mild harshness or ability to frighten Moderate harshness or ability to frighten 4 Moderately severe hallucinations Severe hallucinations Extremely severe hallucinations 7 Continuous hallucinations The Clinical Institute Withdrawal Assessment Alcohol (CIWA-Ar) is a quantification score of patients who are at high risk for developing alcohol withdrawal and or the development of seizures and delirium. Scores of less than 10 usually are not at risk Scores of 10-14 indicate moderate withdrawal Scores of greater than or equal to 1 indicate severe withdrawal Visual Disturbances: Does the light appear to be too bright? Is its colour different? Does it hurt your eyes? Are you seeing anything that is disturbing to you? Are you seeing things you know are not there? 0 Not present 1 Very mild sensitivity Mild sensitivity Moderate sensitivity 4 Moderately severe hallucinations Severe hallucinations Extremely severe hallucinations 7 Continuous hallucinations Headache, Fullness in Head: Does your head feel different? Does it feel like there is a band around your head 0 Not present 1 Very mild Mild Moderate 4 Moderately severe Severe Very severe 7 Extremely severe Orientation & Clouding of Sensorium: 0 Orientated and can do serial additions 1 Cannot do serial additions or is uncertain about rate Date disorientation by no more than calendar days Date disorientation by more than calendar days 4 Disorientated for place and/or person Total Score = 00 D HR (December/01) Page of

Weight (kg) REFER TO THE ALLERGY SCREEN IN MEDITECH FOR ALLERGY INFORMATION To complete the order form, fill in the required blanks and/or check the appropriate boxes. To delete orders, draw one line through the item and initial. Medication Orders: Prior to instituting medication orders review for possible medication interactions with benzodiazepines and consider discontinuing or reducing the dose of other classes of sedatives or narcotics. If patient greater than years of age in addition to using LORazepam as per the chart below consider reducing the dose. Notify MRP if there are THREE consecutive CIWA-Ar scores greater than 10, despite 1 hours of therapy (may give next dose of Diazepam or LORazepam) Notify MRP if patient experiences RR less than 10, systolic BP less than 90 mmhg, sedation score of 4 or shows new presence of jaundice. Discontinue Diazepam, LORazepam, Haloperidol if CIWA-Ar is less than 10 for 4 hours. Date: Patients Initial CIWA-Ar Score 10-14 Less than years of age Greater than years of age Severe liver disease Severe asthma Respiratory failure Diazepam 10 mg PO/IV q1h PRN to maintain CIWA-Ar score of less greater than LORazepam mg SL/IV q1h PRN to maintain CIWA-Ar score of less greater than Time: Initial CIWA-Ar Score 1 or greater Diazepam 0 mg PO/IV STAT then 10 mg PO/IV q0 minutes PRN to maintain CIWA-Ar score of less greater than LORazepam 4 mg SL/IV STAT then mg IV/SL q0 minutes PRN to maintain CIWA-Ar score of less greater than ** Maximum Diazepam dose is 00 mg in 4 hours ** Maximum LORazepam dose is 0 mg in 4 hours Thiamine 100 mg PO/IV daily x days ( doses total) Multivitamin 1 tablet PO daily Renal Multivitamin 1 tablet PO daily For severe hallucinations/ or agitation: Haloperidol mg PO/ IM/ IV q1-4h PRN until sedated for a maximum of doses/day Note: Haloperidol lowers seizure threshold. Use with caution in first three days. Give doses of diazpeman 0 mg as seizure prophylaxis unless sedation score greater than Venous Thromboembolism Prophylaxis: If not ordered Day 1, MD to reassess starting DVT prophylaxis hospital day Dalteparin,000 units Subcutaneous daily Dalteparin,00 units Subcutaneous daily (if greater than 80 years old or weight less than 40 kg) Heparin,000 units Subcutaneous q8h If Heparin ordered: CBC, APTT, Creatinine prior to initiating therapy if not already ordered and CBC weekly while on therapy Anti-thrombotic compression stockings (if pharmacological prophylaxis contraindicated and reassess for pharmacological prophylaxis daily.) Specify Reason: No DVT Prophylaxis (Specify Reason): Fully mobile Expected length of stay less than days and non-surgical Other: Any history of alcohol withdrawal related seizure Diazepam 0 mg PO/IV q1h x doses greater than Diazepam 10 mg PO/IV q0 minutes PRN to maintain CIWA-Ar score of less greater than LORazepam 4 mg SL/IV q1h x doses greater than LORazepam mg IV/SL q0 minutes PRN to maintain CIWA-Ar score of less greater than Complete additional orders on page PRESCRIBER SIGNATURE 00 D HR (December/01) Page of THIS PPO MUST BE FAXED TO PHARMACY

Sedation Score Assessment Documented Recommended Action Level of Sedation S 1 4 Sleep, easy to arouse Alert, easy to arouse Occasionally drowsy, easy to arouse Frequently drowsy, falls asleep mid-sentence Somnolent, difficult to arouse No action No action No action Increase monitoring and hold benzodiazepines Hold benzodiazepines and notify MRP 00 D HR (December/01) Page 4 of

Weight (kg) REFER TO THE ALLERGY SCREEN IN MEDITECH FOR ALLERGY INFORMATION To complete the order form, fill in the required blanks and/or check the appropriate boxes. To delete orders, draw one line through the item and initial. Hypoglycemia Management Blood glucose testing if patient exhibits signs or symptoms of hypoglycemia PATIENT IS ABLE TO SWALLOW If blood glucose is between.8mmol/l - 4 mmol/l: Give 4 glucose tablets (1mg total)or 17 ml of juice If blood glucose is less than.8 mmol/l: Give glucose tablets (0mg total) OR ml of juice Recheck blood glucose in 1 min and repeat above treatment x 1 if blood glucose remains less than 4 mmol/l Notify MD to reassess glucose lowering therapy PATIENT IS UNABLE TO SWALLOW If blood glucose is less than 4 mmol/l With IV access: Give D0W 0 ml IV push Without IV access: Give Glucagon 1 mg subcutaneous or IM Recheck blood glucose in 1 min Notify MD if blood glucose remains less than 4 mmol/l Additional Orders: Date: Time: PRESCRIBER SIGNATURE 00 D HR (December/01) Page of THIS PPO MUST BE FAXED TO PHARMACY

THIS PAGE BLANK IS 00 D HR (December/01) Page of